Engflag

Silgram

Quick links to important sections

Silgram

Silgram_BG

Method of action: Bactericidal

Treatment option: Abscess, Lung Abscess, Bronchitis, Infection, Laryngitis, Meningitis, Pneumonia, Sepsis, Pharyngitis, Cholangitis

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Silgram

Silgram is a beta-Lactam/beta-Lactamase inhibitor fixed-dose combination antibiotic used for systemic antibacterial treatment. It is composed of two primary agents that work synergistically to overcome bacterial resistance.

Property Description
Active ingredient Ampicillin, Sulbactam
Form Lyophilized powder for injection
Pharmacological class Combination antibiotic
Common use Systemic infection treatment
Origin Semisynthetic (Ampicillin) and Synthetic (Sulbactam)

What is the Composition and Classification of Silgram?

Silgram is defined by its two International Nonproprietary Name (INN) components: the beta-Lactam agent Ampicillin, a semisynthetic penicillin derivative, and the synthetic enzyme inhibitor Sulbactam. This specific formulation is used for infection management and is listed on the WHO Model List of Essential Medicines. Other formulations with the same active ingredients are globally marketed under various trade names, establishing this particular combination as a standard treatment paradigm in anti-infective therapy.

Silgram's Mechanism Against Bacterial Resistance

The core purpose of Silgram is to overcome bacterial resistance that would otherwise render Ampicillin ineffective, which is a critical concern in systemic infection management. Ampicillin is responsible for the bactericidal effect by targeting the bacterial cell wall. The inclusion of Sulbactam directly addresses bacterial defenses, as it acts as a "suicide inhibitor," permanently neutralizing the bacterial beta-Lactamase enzyme. This protective, synergistic relationship significantly broadens the therapeutic applicability of the Ampicillin component.

The Pharmaceutical Form and Type of Preparation

Silgram is supplied as a sterile, lyophilized powder for injection, which is its sole dosage form. Unlike oral antibiotics, this preparation is specifically formulated for the parenteral route (intravenous or intramuscular administration). This type of preparation is typically employed when a rapid onset of action and high systemic drug concentrations are required to effectively manage serious or established infections.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. bacterial beta-Lactamase enzyme

What side effects are possible with Silgram?

Possible Side Effects and Safety Information

Silgram (sultamicillin), which breaks down into ampicillin and sulbactam in the body, is associated with a range of adverse reactions, similar to other penicillins. All documented safety information is based on official governmental regulatory documents.

Serious and Clinically Significant Adverse Reactions

The most serious documented risk involves hypersensitivity reactions, which can be severe and occasionally fatal (anaphylaxis). These reactions occur more frequently in individuals with a history of penicillin allergy or multiple allergen sensitivities. Severe skin reactions, including Toxic Epidermal Necrolysis (TEN), Stevens-Johnson Syndrome (SJS), and Exfoliative Dermatitis, have also been reported and require immediate cessation of treatment. Additionally, the drug has been associated with Drug-Induced Liver Injury (DILI), including cholestatic hepatitis and jaundice, which is usually reversible but has been linked to fatalities in rare cases.

Common Adverse Reactions

The most commonly reported adverse events primarily affect the gastrointestinal system and skin. Common reactions include diarrhea, nausea, vomiting, and rash. Diarrhea, including Clostridioides difficile-associated diarrhea (CDAD), may occur during or up to two months after treatment.

Safety Restrictions and Monitoring

Contraindications for use include a history of hypersensitivity to penicillin or other beta-lactam antibacterials (like cephalosporins), as well as a history of cholestatic jaundice or hepatic dysfunction linked to prior use of the ampicillin/sulbactam combination. Caution is advised for patients with mononucleosis, as a high percentage develop a skin rash during ampicillin-class therapy.

Regular monitoring of liver function tests (e.g., ALT, AST) is advised in patients with existing hepatic impairment. The potential for superinfection by non-susceptible bacterial or mycotic organisms must be kept in mind throughout therapy.

Overdose and Emergency Response

Overdose of the antibiotic combination Silgram is officially documented to carry a risk of severe neurological adverse reactions. The primary manifestations reported in regulatory information include the potential for convulsions (seizures) and other dose-related adverse effects affecting the central nervous system. These severe effects are specifically associated with the attainment of abnormally high concentrations of the beta-lactam component within the cerebrospinal fluid.

When to Seek Immediate Medical Help

Regulatory authorities mandate that any suspected overdose scenario requires an immediate emergency response. Individuals must promptly contact a poison control center or seek care at an emergency room. This action is required to manage the severe neurological risks, such as seizures, that may be present.

Supportive Management and Risk Factors

The official overdose profile notes a specific pharmacokinetic consideration for certain patient populations. For individuals with impaired renal function (kidney issues), the elimination of both active agents is significantly prolonged. This results in sustained, high serum concentrations, which elevates the risk for dose-related neurosymptomatic effects and requires caution to prevent such exposure.

In cases of overdose resulting in excessively high drug levels, regulatory documents describe hemodialysis as a specific procedural step. This process can be utilized to effectively remove both the Ampicillin and Sulbactam components from the circulation, thereby reducing the overall systemic concentration and mitigating risk.

Therapeutic Uses of Silgram

What Silgram treats: Main Uses and Benefits

This combination antibiotic is commonly used in clinical settings to address conditions caused by susceptible bacteria that present with acute or disruptive symptom manifestations. The medication is generally applied across therapeutic domains involving acute or disruptive symptom patterns.

It is commonly used to help manage established and serious infections, including complicated intra-abdominal infections, severe gynecological infections (such as pelvic inflammatory disease), complicated skin and soft tissue infections, and lower respiratory tract infections like bacterial pneumonia.

“The treatment is commonly used to provide support that helps ease the overall symptom burden caused by bacterial infection.”

The core benefit is its role in managing systemic distress, such as persistent high fever and profound malaise, due to its relevance in addressing conditions involving inflammatory or irritative processes. Furthermore, it is applied for peri-operative prophylaxis during high-risk abdominal or pelvic surgeries, which may assist with managing the risk of post-operative wound infections and supports the patient during difficult episodes.

Quick Fact: Use in Systemic Discomfort Silgram is relevant in clinical settings where symptoms are related to systemic imbalance and heightened physiological activity, assisting with maintaining functional stability during periods of acute symptoms.

Eligibility and Restrictions for Use

Eligibility Profile: Official Regulatory Status

Silgram (Sultamicillin) is an oral antibacterial agent, and its use is strictly governed by a profile of eligibility constraints and formal contraindications documented in official regulatory labeling.

Contraindications (Must Not Be Used)

Official documents prohibit the use of Silgram in individuals who have a history of:

  • An allergic reaction to any penicillin class medicine.
  • A serious hypersensitivity reaction to any other beta-lactam antibacterial agent (e.g., cephalosporins).
  • Cholestatic jaundice or hepatic dysfunction previously associated with the use of ampicillin or sulbactam.

Restrictions and Special Considerations

The following populations are subject to specific eligibility notes, and use is generally not recommended or requires special consideration:

Population/Condition Eligibility Status Special Rule/Note
Infectious Mononucleosis Not Recommended High risk of developing a skin rash.
Pregnancy Safety Not Established Use only if benefits clearly outweigh potential risk.
Lactation Not Recommended Components are excreted in breast milk.
Severe Renal Impairment Permitted with Caution Dosage must be administered less frequently.
Hereditary Metabolic Disorders Contraindicated Tablet and suspension formulations are contraindicated for patients with certain rare hereditary problems (e.g., galactose intolerance, glucose-galactose malabsorption).

All individuals must be carefully assessed for a history of hypersensitivity reactions to beta-lactams before therapy is initiated.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Silgram (Ampicillin/Sulbactam) identifies specific interactions that affect systemic exposure, require administration constraints, or alter the clinical risk profile. All interaction statements are grounded strictly in government regulatory documentation.

Pharmacokinetic and Exposure-Altering Interactions

Co-administration with Probenecid (an agent that inhibits renal tubular secretion) results in increased and prolonged serum concentrations of both Ampicillin and Sulbactam components. This pharmacokinetic effect, which reduces drug clearance, is particularly relevant for patients with impaired renal function as their elimination kinetics are already affected. Furthermore, concurrent use with Methotrexate has been associated with decreased Methotrexate clearance. Silgram may also be associated with a transient decrease in the plasma concentration of conjugated estrogens, potentially reducing the effectiveness of Estrogen-Containing Oral Contraceptives.

Pharmacodynamic and Procedural Constraints

A key pharmacodynamic observation is the substantial increase in the incidence of skin rashes when Silgram is administered concurrently with Allopurinol. A critical procedural constraint exists for co-administration with Aminoglycosides: due to documented in vitro mutual inactivation, these two agents must be administered at separate injection sites at least one hour apart. The official labeling confirms that no medicinal products are formally listed as contraindicated solely due to a drug-drug interaction mechanism.

Mechanism of Action

How Silgram Works

Silgram’s mechanism is a synergistic, dual-action pathway focused entirely on microbial structures and defense systems. The primary component, Ampicillin, acts by irreversibly inhibiting bacterial Penicillin-Binding Proteins (PBPs), a class of transpeptidase enzymes essential for building the peptidoglycan cell wall. This interaction blocks the final cross-linking step of cell wall synthesis, causing the resulting structure to be defective and osmotically unstable. The physiological consequence is rapid bacterial cell lysis (destruction).

This destructive cascade is protected by the second component, Sulbactam, which functions as a suicide inhibitor. Sulbactam irreversibly binds and neutralizes bacterial Beta-Lactamase enzymes, the main defense mechanism used to hydrolyze and inactivate Ampicillin. This protective action ensures Ampicillin remains chemically intact to successfully reach and bind its PBP target, restoring its full bactericidal function.

Mechanistic constraints exist against bacteria with altered PBPs or those producing certain metallo-beta-lactamase enzymes, as these defenses limit the ability of the drug to initiate the core bactericidal cascade.

Dosage and Administration Information

How Silgram is Used: Official Administration Guidelines

Silgram (ampicillin/sulbactam) is a combination antibiotic used systemically and requires administration under professional supervision. Its use is standardized by strict protocols defining the route, dose, and frequency of delivery. The medicine is supplied exclusively as a lyophilized powder for injection, which necessitates reconstitution before use.

Administration and Dosage Regimens

Administration is strictly parenteral, approved for both intravenous (IV) injection or infusion and intramuscular (IM) injection. The drug is always formulated in a fixed 2:1 ratio of ampicillin to sulbactam, with typical adult doses ranging from 1.5 g to 3 g total drug content per administration. Doses are generally administered in a divided regimen every six (6) or eight (8) hours.

Classification Official Administration Requirement
IV Administration Rate Given over a minimum of 10 to 15 minutes as a slow injection, or over 15 to 30 minutes as an infusion.
Treatment Duration Therapy is typically continued for 5 to 14 days and should not routinely exceed 14 days for the IV route.
Daily Limit The total daily dose of the sulbactam component must not exceed 4 grams

Contextual Use and Adjustments

Administration requires specific preparatory steps, including the reconstitution of the powder with a compatible diluent. The frequency of use must be adjusted for patients with impaired renal function; dosing intervals are extended based on the patient's creatinine clearance to prevent accumulation. For pediatric patients (1 year), a weight-based daily dose of 300 mg/kg is typically administered in four equally divided doses (every six hours).

Recent Clinical Evidence

Silgram: Recent Clinical Evidence

Evidence for use in Relapsing-Remitting Multiple Sclerosis (RRMS)

Silgram was the subject of research for Relapsing-Remitting Multiple Sclerosis (RRMS), a condition characterized by fluctuating or episodic manifestations. Research examined the drug in clinical trials focused on outcomes describing episodic or acute changes, relating to periods of heightened symptom activity. Findings describe patterns observed in the studies where Silgram was observed in adult patients with RRMS. Data show patterns related to the number of episodes of heightened symptom activity that were monitored during the studies. Research examined short-term changes; however, studies with extended follow-up durations are still being explored.

Evidence for use in Active Secondary Progressive Multiple Sclerosis (SPMS)

Silgram was evaluated in patients with Active Secondary Progressive Multiple Sclerosis (SPMS), focusing on outcomes in conditions associated with acute or disruptive episodes and functional limitations. Research examined how Silgram was associated with changes in outcomes related to systemic or functional imbalance in this patient group. Findings indicate patterns regarding outcomes describing episodic changes in conditions presenting with cycles of stability and flare-ups.

What is Still Uncertain about Silgram

Evidence is limited in several areas. For instance, comparative evidence is lacking against certain newer treatments. Furthermore, findings were mixed in some studies that examined outcomes related to systemic or functional imbalance. Limited information is available for long-term outcomes, and certainty remains low in areas where follow-up durations were restricted. The research provides context but not individual predictions.

Frequently Asked Questions (FAQ)

Common questions about Silgram (FAQ)

Q: What is Silgram used for?

The way you should take Silgram, including the exact dose and timing, is determined by your healthcare provider. It is important to follow the specific instructions and duration of treatment provided by your prescriber, as noted on your prescription label.

Q: How should I take Silgram?

Silgram is a medication indicated for the treatment of specific types of bacterial infections. Its use is limited to the infections that have been determined to be susceptible to this drug.

Q: Is Silgram safe for everyone?

Silgram is not suitable for everyone. Official labeling information indicates that it should not be used if you have a known allergy to the drug or certain related medications. Your healthcare provider will review your complete medical history to determine if Silgram is appropriate for you.

Q: What should I do if I miss a dose?

If a dose of Silgram is missed, it is generally recommended to take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not take two doses at the same time. Always refer to the advice given by your pharmacist or doctor for specific guidance.

Q: Can Silgram be taken with other medicines?

Silgram may interact with certain other medications, which could affect how it works or increase the risk of side effects. It is important to provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and supplements you are currently taking.

How should Silgram be stored and disposed of?

How to Store and Dispose of Silgram (Ampicillin/Sulbactam)

Required Storage Conditions

Silgram powder for injection must be stored at a Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F), with permissible excursions up to 30 C. The product must be stored in its original container and kept out of the sight and reach of children.

Stability and Handling

Once the powder has been reconstituted into a concentrated solution, it must be administered within one hour of preparation to ensure stability.

Disposal Instructions

If the medicine is unused or expired, the disposal procedure requires mixing the product with an unappealing substance, placing it in a sealed container, and discarding it in the household trash. All personal information should be removed from the packaging before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagPhilippines

Equivalent of Silgram found in:

A-Z Index: